Kailera Therapeutics, Inc. (KLRA) Insider Trading
0 insider purchases in the last 7 days
No open market insider purchases at Kailera Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track KLRA on your watchlist.
Start for FreeAbout Kailera Therapeutics, Inc. Insider Trading
5 insiders at Kailera Therapeutics, Inc. (KLRA) have purchased stock in the past 90 days, totaling $326.8M across 5 transactions (20,421,876 shares).
The most recent purchase was by 10%+ Owner RTW INVESTMENTS, LP on April 20, 2026 — a $8.0M buy of 500,000 shares at $16.00, bringing his total holdings to 10,776,820 shares.
Insiders who purchased: BAIN CAPITAL INVESTORS LLC (10%+ Owner, 1 buy totaling $134.4M); Kaplan Andrew T. (Director, 1 buy totaling $134.4M); Bain Capital Life Sciences Investors, LLC (10%+ Owner, 1 buy totaling $25.0M); Koppel Adam (Director, 1 buy totaling $25.0M); RTW INVESTMENTS, LP (10%+ Owner, 1 buy totaling $8.0M).
This insider buying is notable given that KLRA had no recorded open market purchases in the nine months before that.
With 5 different insiders buying in the same 90-day window, this qualifies as cluster buying at KLRA — a pattern that research suggests can signal conviction among management.
Track KLRA insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.